Search results for "From ACP Journal Club"
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes
The review shows that, contrary to specialty recommendations, there is no reason not to use regular human insulins, which are less costly than analogue insulins, said an ACP Journal Club commentary. ... The following commentary by Mayer B. Davidson, MD,
May 2019
In type 2 diabetes with periodontitis, intensive periodontitis treatment improved glycemic control at 1 year
referrals, the ACP Journal Club commentary said. ... The following commentary by Zubin Punthakee, MD, was published in the ACP Journal Club section of the April 16 Annals of Internal Medicine.
May 2019
In diabetes with no CVD, aspirin reduced serious vascular events but increased major bleeding at 7.4 years
according to an ACP Journal Club commentary. ... The following commentary by Gaetano Santulli, MD, was published in the ACP Journal Club section of the Dec.
January 2019
Risk scores overestimated risk for CVD in newly diagnosed type 2 diabetes
Available risk scores are in need of recalibration but still serve as useful decision-making tools, according to an ACP Journal Club commentary. ... The study was published in the September Diabetes Care. The following commentary by Michael Tanner, MD,
December 2018
Review: Evidence is inconclusive on metabolic surgery vs. medical treatment for microvascular complications in T2DM
The following commentary by Reema Shah, MD, was published in the ACP Journal Club section of the July 17 Annals of Internal Medicine. ... All articles from the August 10, 2018, ACP Diabetes Monthly Newsletter.
August 2018
In high-risk T2DM, canagliflozin reduced CV events regardless of baseline renal function
ACP Journal Club commentary. ... Herrington, MD, Doreen Zhu, MBChB, and Richard Haynes, DM, was published in the ACP Journal Club section of the Feb.
March 2019
DPP-4 inhibitors are less effective than metformin for reducing hemoglobin A1c
The study was published in BMJ on March 12. The following commentary by Saurav Chatterjee, MD, was published in the ACP Journal Club section of the July 17 Annals of Internal ... All articles from the August 10, 2012, ACP Diabetes Monthly Newsletter.
August 2012
In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER
Exenatide is still an effective alternative for patients who cannot tolerate semaglutide due to gastrointestinal adverse events, noted the ACP Journal Club commentary. ... in the ACP Journal Club section of the April 17 Annals of Internal Medicine.
May 2018
In high-risk pregnant women, an individualized lifestyle intervention reduced gestational diabetes mellitus
The study, referred to as the RADIEL trial, was published in the January Diabetes Care.The following commentary by Lorraine Lipscombe, MD, MSc, was published in the ACP Journal Club section ... All articles from the January 8, 2016, ACP Diabetes Monthly
January 2016
Intensive glucose-lowering in type 2 diabetes was linked to hypoglycemia in high-complexity patients
The following commentary by Daniel I. Steinberg, MD, FACP, was published in the ACP Journal Club section of the Sept. ... All articles from the October 7, 2016, ACP Diabetes Monthly Newsletter.
October 2016